Sort
51,570 grants matching “autoimmune disease”
B cell depletion to prevent autoimmunity
$396,705Kavita Dhodapkar · Emory University · R01 · FY2021 · AR
HLA/KIR Region Genetics in Pediatric Arthritis
$396,702David N. Glass · Cincinnati Childrens Hosp Med Ctr · U01 · FY2009 · AI
Inflammasome-gasdermin axis in bullous pemphigoid
$396,696Zhi Liu · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AR
Purinergic modulation of the autoimmune vascular phenotype
$396,640Jason Knight · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
Targeting Fnip1 to disrupt B cell development, metabolism, and transformation
$396,614Brian M Iritani · University Of Washington · R01 · FY2015 · AI
Receptor Editing in Autoimmune and Normal Mice
$396,601Ann J Feeney · Scripps Research Institute, The · R01 · FY2007 · AI
CdK5, OX40, and Immune Tolerance in Uveitis
$396,592John James Letterio · Case Western Reserve University · R01 · FY2017 · EY
CdK5, OX40, and Immune Tolerance in Uveitis
$396,592John James Letterio · Case Western Reserve University · R01 · FY2016 · EY
Role of the thymic epithelium on the outcome of allogeneic transplantation
$396,588Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · AI
The Role of Estrogen Receptor Alpha Variant Size and Localization in Modulating TLR7-Induced Inflammation
$396,583Melissa A Cunningham · Medical University Of South Carolina · R01 · FY2023 · AR
Regulation of Leukocyte Integrins in Inflammatory Cell Recruitment
$396,567Triantafyllos Chavakis · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
$396,554Leonore A. Herzenberg · Stanford University · R01 · FY2024 · AI
Pre-and Postdoctoral Training Program in Immunology
$396,521University Of Rochester · T32 · FY2004 · AI
Phase II Trial of methotrexate in myasthenia gravis FDA IND#:101,306 01/06/2008
$396,508Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2012 · FD
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
$396,505Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2012 · FD
Mechanisms of human immune modulation by oral N-acetylglucosamine
$396,477Michael Demetriou · University Of California-Irvine · R01 · FY2015 · AT
Costimulation Genes and Pathways in Multiple Sclerosis
$396,469David A. Hafler · Yale University · P01 · FY2010 · AI
Maternal Central Immune Tolerance in Reproduction
$396,442Margaret G Petroff · Michigan State University · R01 · FY2022 · HD
Deaf1 isoforms control changes in PTA expression in the NOD PLN during T1D pathog
$396,431Charles Garrison Fathman · Stanford University · R01 · FY2012 · AI
Dendritic Cell Biology and Therapy
$396,430Olivera J Finn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Immunobiology of CTL Responses to Exogenous Antigens
$396,398Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · AI
Regulation of Natural Killer Cell Activation Receptors, NKG2D and CD16
$396,396John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH
$396,392Fredrick M Wigley · Johns Hopkins University · P50 · FY2007 · HL
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
$396,354Steven A Webber · Vanderbilt University Medical Center · U01 · FY2018 · AI
T cells in Chronic Pelvic Pain
$396,351Praveen Thumbikat · Northwestern University At Chicago · R01 · FY2016 · DK